MAGNOLIA, Texas--(BUSINESS WIRE)--Pernix™ Therapeutics Holdings, Inc. (NYSE Amex: PTX), an integrated specialty pharmaceutical company primarily focused on the pediatric market, today announced the appointment of Joseph T. Schepers as Director of Investor Relations and Corporate Communications. In the new position, Mr. Schepers will be responsible for leading the Company’s investor relations and media relations program. He will report to Cooper Collins, President and Chief Executive Officer of Pernix.
